![Anne Altmeyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 71 091 $ au 30/06/2026
Anne Altmeyer is President & Chief Executive Officer at TigaTx, Inc. since 2024 and has been an Independent Director at Corbus Pharmaceuticals Holdings, Inc. since 2022.
Former roles include Chief Business Officer at Sigilon Therapeutics, Inc. from 2019 to 2021, Chief Business Officer at Adicet Bio, Inc. from 2016 to 2019, Vice President-Business Development & Licensing at Baxalta, Inc. from 2015 to 2016, and Vice President-Business Development & Licensing at Novartis Corp.
from 2004 to 2015.
Education includes graduate studies at the University of Medicine & Dentistry of New Jersey, a doctorate from the University of Strasbourg, and an MBA from Rutgers University-New Brunswick.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 7 579 ( 0,04 % ) | 71 091 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 20/09/2022 |
TigaTx, Inc.
 TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Directeur Général | 01/01/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| ADICET BIO, INC. | Corporate Officer/Principal | 01/01/2019 |
| BAXALTA INC | Corporate Officer/Principal | 01/01/2016 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/08/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Rutgers University-New Brunswick
 Rutgers University-New Brunswick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
TigaTx, Inc.
TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
